Critical Appraisal of Economic Evaluation Studies (Part I): Types of Studies. Cost-Benefit Analysis
DOI:
https://doi.org/10.25751/rspa.19073Keywords:
Biomedical Research; Cost-Benefit Analysis; Evaluation Studies; Models, EconomicAbstract
Economic evaluation studies are valuable and indispensable tools in the assessment of health technologies, taking into account (but not exclusively) their costs. In fact, there are different types of economic evaluation studies, which can be generally classified as partial or full economic evaluations. While partial economic evaluations solely aim to quantify costs, full economic evaluations take into account both costs and consequences (health outcomes and clinical effectiveness) of the assessed alternatives. This latter group of studies includes cost-benefit, cost-effectiveness, and cost-utility analysis, which differ in the approach used to express consequences. In cost-benefit studies, consequences and health outcomes are expressed in monetary units along with costs. This allows, for example, the assessment of whether the benefits (consequences or health gains as expressed in monetary units) of a given alternative are higher than its costs. While decision-makers may more easily interpret cost-benefit studies, the monetary valuation of health outcomes (such as gains in life years or in quality of life) is not without controversy – this valuation is typically based on the human capital, contingent valuation, or revealed preferences methods, each one with their own limitations.
Downloads
References
Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16:231-50.
2. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2005.
3. Rudmik L, Drummond M. Health economic evaluation: Important principles and methodology. Laryngoscope. 2013;123:1341-7. doi: 10.1002/lary.23943.
4. Carvalho B, Tan J, Macario A, El-Sayed YY, Sultan P. A cost analysis of neuraxial anesthesia to facilitate external cephalic version for breech fetal presentation. Anesth Analg. 2013;117:155-9. doi: 10.1213/ANE.0b013e31828e5bc7.
5. Azevedo LF, Costa-Pereira A, Mendonça L, Dias CC, Castro-Lopes JM. The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal. Eur J Health Econ. 2016;17:87-98. doi: 10.1007/s10198-014-0659-4.
6. Ho PT, Carvalho B, Sun EC, Macario A, Riley ET. Cost-benefit analysis of maintaining a fully stocked malignant hyperthermia cart versus an initial dantrolene treatment dose for Maternity Units. Anesthesiology. 2018;129:249-
59. doi: 10.1097/ALN.0000000000002231.
7. Griffin RC. The Fundamental principals of cost-benefit analysis. Water Resources Researc. 1998;34:2063-71.
8. Kneisner TJ, Viscusi WK, Woock C, Ziliak JP. The Value of a Statistical Life. Evidence from a Panel Data. Center for Policy Research: Working paper No. 122. 2011.
Downloads
Published
How to Cite
Issue
Section
License
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.